Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY | 17-AAG |
FIMM | Tanespimycin |
CTRPv2 | tanespimycin |
PharmacoGx | 17-AAG |
Database | Identifier |
---|---|
Smiles: | CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC |
Inchikey: | AYUNIORJHRXIBJ-TXHRRWQRSA-N |
Pubchem: | 6505803 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LGALS3 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | PLOD1 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | TTC23 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | TXN | CCLE | pan-cancer | AAC | 0.29 | 2e-09 |
mRNA | KCNMB2 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-09 |
mRNA | SMAD3 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
mRNA | TGFBI | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-09 |
mRNA | NT5E | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
mRNA | TMEM214 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
mRNA | NRXN1 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-09 |